JOINT BASE LEWIS-MCCHORD, Wash., July 10, 2019 /PRNewswire/ -- The Defense Health Agency's Connected Health Branch is pioneering enhanced care for the military community by using social media to deliver anonymous, free, quick self-assessments that identify a user's symptoms of various mental health conditions and recommend innovative resources, such as mobile applications and podcasts, to help them

LOS ALAMITOS, Calif., July 10, 2019 /PRNewswire/ -- Discovery Behavioral Health, Inc. today announced the appointment of Jonatha

WORCESTER, Mass., July 10, 2019 /PRNewswire/ -- On Tuesday, July 9, the Hunger to Health Collaboratory (H2HC), in cooperation with Congressman Jim McGovern, UMass Memorial Health Care and UMass Medical School, convened statewide health care leaders for a results-driven conversat

WALTHAM, Mass., July 10, 2019 /PRNewswire/ -- Fresenius Medical Care, the world's largest provider of dialysis products and services, is pleased the U.S. administration's plans for changing the way care is provided to people with kidney disease supports its existing strategy. The company has long worked on various initiatives to promote home dialysis, improve access to tra

SAN DIEGO, July 10, 2019 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for opicapone, a novel, once-daily, oral, selective catechol-O-methyltransferase (COMT) inhibitor as an adjunctive treatment to levodopa/carbidopa in patients with Parkinson'

WASHINGTON, July 10, 2019 /PRNewswire/ -- The Health Coalition on Liability and Access (HCLA) today announced its support of H.R. 3656, the Accessible Care by Curbing Excessive LawSuitS Act (ACCESS Act), a comprehensive medical liability reform bill introduced by Representative Richard Hudson (R-N.C.).The ACCESS Act is

ROCKVILLE, Md. and SHANGHAI, July 10, 2019 /PRNewswire/ -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, and I-Mab Biopharma (I-Mab), a China and U.S.

NEW YORK, July 10, 2019 /PRNewswire/ -- There's no better time to embrace soccer than right now as the U.S. Women's National Soccer Team just won its fourth World Cup title on Sunday, celebrated by a ticker tape parade today in New York City. Soccer is a not only a favorite sport and pastime for people all over the world but it's great fo

BOSTON, July 10, 2019 /PRNewswire/ -- XRHealth, formerly known as VRHealth, is the leader in extended reality and therapeutic applications, today announced that they are opening their platform to

SEATTLE, July 10, 2019 /PRNewswire/ -- Impel NeuroPharma, a late-stage biopharmaceutical company focused on the development and commercialization of transformative therapies for patients living with central nervous system (CNS) disorders with high unmet medical needs, today announcedthat it will present four scientific abstracts at the 61